Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Novel EGFR inhibitors discovered by Astellas researchers

March 5, 2009

Trabectedin beneficial in some castration-resistant prostate cancer patients

March 5, 2009

Multiple Myeloma Research Foundation gives grants for two novel drug candidates

March 4, 2009

FDA provides complete response to Erbitux head and neck cancer sBLA

March 4, 2009

IDMC recommends continuation of clinical trial of Hana's Marqibo in ALL

March 4, 2009

Cediranib shows potential in docetaxel-resistant prostate cancer

March 4, 2009

New Met kinase inhibitors for cancer reported by Merck KGaA

March 4, 2009

Recent KuDOS and Cancer Research Technology patent describes novel DNA-PK inhibitors

March 4, 2009

Millennium initiates two phase II trials for Aurora A kinase inhibitor MLN-8237

March 4, 2009

Disulfiram, a DNMT1 inhibitor with activity relevant to prostate cancer

March 4, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...